Artemis Q4 Revenue up 7%, EBITDA Rises 21%, Net Profit Jumps 60%

14 May 2025 CW Team

The Board of Directors of Artemis Medicare Services today approved the company’s audited financial results for the 4th quarter (Jan to Mar) and 12M (Apr to Mar) for the financial year 2024 – 25.

For the quarter ended March 31, 2025 Artemis Medicare Services, on a consolidated level, registered a gross revenue of Rs 2,521 Million, an increase of 7.0 per cent over the same period last fiscal. For the fiscal year (April – March), the company’s gross revenue closed at Rs 9,819 Million, an increase of 6.5 per cent over the same period last fiscal. The Board of Directors have recommended a final dividend of 45 per cent per Equity Share of face value of Re 1 each for FY25, subject to the approval of the shareholders at the ensuing Annual General Meeting (AGM) of the Company.

Commenting on the company’s performance, Onkar Kanwar, Chairman, Artemis Medicare Services said “Artemis concluded FY25 on a strong and positive trajectory, delivering consistent performance and steady growth across the year. We have continued to advance in both clinical excellence and operational capabilities, reaffirming our commitment to provide high-quality, accessible healthcare to the communities we serve. During the year we also inaugurated our third tower, which will be commissioned in a phase-wise manner to accommodate the increasing demand from our growing patient base.

To fuel our next growth phase, we raised Rs 3.30 billion from the International Finance Corporation (IFC), enabling strategic expansion across Delhi NCR and select Tier 2 cities through both brownfield and greenfield projects. The Board has approved a long-term Operations & Management and Medical Services Agreement for a 300+ bed super-speciality hospital in Raipur. This deal marks a key step in expanding our footprint in Central India and reinforces our mission to deliver advanced healthcare solutions across geographies. As we look ahead, our unwavering focus remains on creating long-term value for our patients, shareholders, and employees, while building Artemis into one of India’s most trusted and respected healthcare brands.”

The Board of Directors of Artemis Medicare Services today approved the company’s audited financial results for the 4th quarter (Jan to Mar) and 12M (Apr to Mar) for the financial year 2024 – 25.For the quarter ended March 31, 2025 Artemis Medicare Services, on a consolidated level, registered a gross revenue of Rs 2,521 Million, an increase of 7.0 per cent over the same period last fiscal. For the fiscal year (April – March), the company’s gross revenue closed at Rs 9,819 Million, an increase of 6.5 per cent over the same period last fiscal. The Board of Directors have recommended a final dividend of 45 per cent per Equity Share of face value of Re 1 each for FY25, subject to the approval of the shareholders at the ensuing Annual General Meeting (AGM) of the Company.Commenting on the company’s performance, Onkar Kanwar, Chairman, Artemis Medicare Services said “Artemis concluded FY25 on a strong and positive trajectory, delivering consistent performance and steady growth across the year. We have continued to advance in both clinical excellence and operational capabilities, reaffirming our commitment to provide high-quality, accessible healthcare to the communities we serve. During the year we also inaugurated our third tower, which will be commissioned in a phase-wise manner to accommodate the increasing demand from our growing patient base.To fuel our next growth phase, we raised Rs 3.30 billion from the International Finance Corporation (IFC), enabling strategic expansion across Delhi NCR and select Tier 2 cities through both brownfield and greenfield projects. The Board has approved a long-term Operations & Management and Medical Services Agreement for a 300+ bed super-speciality hospital in Raipur. This deal marks a key step in expanding our footprint in Central India and reinforces our mission to deliver advanced healthcare solutions across geographies. As we look ahead, our unwavering focus remains on creating long-term value for our patients, shareholders, and employees, while building Artemis into one of India’s most trusted and respected healthcare brands.”

Resources

09 Mar 2026

Haworth India Hosts Women’s Leadership Panel Series

Haworth India marked International Women’s Day by hosting a leadership roundtable series titled ‘Give to Gain’, bringing together senior women leaders from architecture and design firms, corporates and project management consultancies. The series has been conducted in Delhi and Mumbai, with upcoming sessions scheduled in Bengaluru and Hyderabad on 27 March 2026. Structured as moderated panel discussions followed by audience interaction, the initiative examined the business impact of women’s leadership and the role of inclusive workplaces in supporting professional growth. Manish Khan..

Real Estate

09 Mar 2026

Max Estates Secures RERA For Max One Project

Max Estates has secured RERA approval (UPRERA No.: UPRERAPRJ9759) for its Max One development around Max Towers in Sector 16B, Noida, bringing renewed progress to a project previously stalled following the insolvency of its earlier developer. Spread across around 10 acres with an estimated development potential of about 2.5 million sq ft, Max One is planned as an integrated mixed-use campus combining serviced residences, premium offices, retail spaces and a private club. The project is expected to generate total sales potential of about Rs 20 billion along with an estimated annuity rental inc..

Real Estate

09 Mar 2026

Hindware Introduces Starc Smart Wall Mount Toilet

Hindware has introduced the Starc Smart Wall-Mount Toilet under its Hindware Italian Collection, designed to combine automation, hygiene and contemporary bathroom aesthetics. The model features automatic flushing, sensor-based seat opening and closing, and remote-controlled functions. It also includes an oscillating water spray and warm air dryer for cleaning, along with a self-cleaning nozzle designed to maintain hygiene. Additional features include adjustable heated seating, customisable water temperature and pressure settings, a foot-touch flush system and an LCD control interface. The wa..